drugset / Trial / NCT03065556

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

NCT03065556 ↗

Phase 2 Completed 89 enrolled Therapeutics, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This Phase 2 study (Study 203) has been designed to determine and compare the efficacy and safety of 188-0551 Solution and Vehicle Solution applied twice daily for up to four weeks in subjects with plaque psoriasis. Subjects will be instructed to apply the test article (188-0551 Solution or Vehicle Solution) to all psoriasis plaques within the designated Treatment Area twice daily for four weeks (Study Day 29), unless the investigator verifies the subject's psoriasis has cleared at Day 15, then test article application will be for 2 weeks (Study Day 15).

Timeline

Start
2017-01-26
Primary completion
2017-07-06
Completion
2017-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject 188-0551 Unknown — Topical

Indications